FAK/Src overexpression and/or activation occur in most epithelial ovarian cancers and are significantly associated with poor patient survival (Sood et al., 2004; Wiener et al., 2003; Huang et al., 2013). The gene discussed is SRC; the disease is ovarian carcinoma.